Skip to main content
Deborah Armstrong, MD, Oncology, Baltimore, MD, Johns Hopkins Hospital

DeborahKArmstrongMD

Oncology Baltimore, MD

Professor of Oncology, Professor of Gynecology and Obstetrics, Johns Hopkins University School of Medicine; Director, Breast and Ovarian Surveillance Service

Dr. Armstrong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Armstrong's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1991
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1984 - 1987
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1984

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1988 - 2024
  • VA State Medical License
    VA State Medical License 2022 - 2024
  • PA State Medical License
    PA State Medical License 1986 - 2022
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2014
  • America's Top Doctors for Cancer Castle Connolly, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • A phase I study of veliparib incorporated into front-line platinum based cheotherpy and bevacizumab in epithelial ovarian cancer (NCT00989651): A GOG/nrg trial. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • Advisers to the FDA Back First Over-the-Counter Birth Control Pill
    Advisers to the FDA Back First Over-the-Counter Birth Control PillMay 10th, 2023
  • Hyperthermic Intraperitoneal Chemotherapy May Benefit Some Women with Ovarian Cancer
    Hyperthermic Intraperitoneal Chemotherapy May Benefit Some Women with Ovarian CancerMarch 10th, 2022
  • Drug Boosts Survival for Women with Advanced Ovarian Cancer
    Drug Boosts Survival for Women with Advanced Ovarian CancerMarch 25th, 2021
  • Join now to see all

Committees

  • External Advisory Board Member, Fred Hutchinson Cancer Research Center, University off Washington 2017 - Present
  • Scientific Advisory Committee Member, Ovarian Cancer Research Alliance 2016 - Present
  • Ovarian cancer contributor, UpToDate 2014 - Present
  • External Advisory Committee Member, Mayo Clinic Ovarian Cancer SPORE 2014 - Present
  • Advisory Committee Member, The Marsha Rivkin Center for Ovarian Cancer Research 2008 - Present
  • Member, chair 2017-2020, Department of Defense, Congressionally Directed Medical Research Program, Ovarian Cancer Research Program 2007 - Present
  • Medical and Scientific Advisory Board, National Ovarian Cancer Coalition 2006 - Present
  • co-Chair 2018-2020, NIH Ovarian Task Force, Gynecologic Cancer Steering Committee 2014 - 2020
  • Chair, 2014-2016, Oncology Drugs Advisory Committee, FDA 2011 - 2016

Professional Memberships

Hospital Affiliations

Industry Relationships

  • Independent Data Monitoring Committee Member, DUO-E Trial, AstraZeneca2020 - Present
  • Independent Data Monitoring Committee Member and Chair, DUO-O Trial, AstraZeneca2018 - Present